Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
ERTACZO |
| Manufacturer |
|
Ortho Neutrogena Corporation |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Azole antifungal. |
| Generic Name |
|
Sertaconazole nitrate 2%; crm. |
| Indications |
|
Interdigital tinea pedis in immunocompetent patients. |
| Children |
|
Not recommended. |
| Adults |
|
Dry area first. Apply to affected and adjacent areas twice daily for 4 weeks. |
| Precautions |
|
Discontinue if sensitization or excessive irritation occurs. Avoid eyes, other mucous membranes. Avoid occlusion. Reevaluate if no improvement after 2 weeks. Elderly. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Local reactions. |
| How Supplied |
|
Crm—15g, 30g |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
